The ceremony to announce and honor reputable pharmaceutical businesses in 2025 took place at Ho Guom Theater (Hanoi) on 8/1.
As Vietnam's pharmaceutical industry enters a development phase with increasing demands for quality, transparency, and social responsibility, reputation becomes a crucial measure of a business's capabilities. Beyond reflecting business results, reputation also demonstrates adherence to standards, strategic consistency, and the trust a company builds with the market.
According to Vietnam Report, the ranking of reputable pharmaceutical companies is based on scientific and objective principles, using three main criteria: financial capacity; media reputation; and surveys of relevant stakeholders conducted in October-November 2025. The ranking aims to reflect the stable operational capacity and long-term development orientation of businesses in the pharmaceutical industry.
 |
Thai Minh Pharmaceutical honored at the event. Photo: Thai Minh |
Han Ngoc Anh, CEO of Thai Minh Pharmaceutical, stated that the company's continued inclusion in the Top 10 for 2025 is a result of persistent efforts to build standards in quality, transparency, and governance over many years. "We define sustainable development not just as growth in scale, but as creating long-term value for the community, partners, and consumers through commitments consistently fulfilled over time", Han Ngoc Anh said.
Since its establishment in 2012, Thai Minh Pharmaceutical has positioned quality as a core principle, from research and product development to distribution. The company focuses on investing in scientific foundations, standardizing processes, and controlling all stages in the value chain, ensuring products delivered to consumers meet safety and efficacy requirements.
 |
Thai Minh Pharmaceutical's quality research lab, where scientific investment is a pillar of the company's development strategy. Photo: Thai Minh |
Additionally, Thai Minh has progressively refined its nationwide distribution system towards transparency and professionalism. The company identifies building and maintaining trust with its network of partners, pharmacies, and consumers as a key factor contributing to its sustainable market reputation.
Throughout its development, Thai Minh Pharmaceutical consistently pursues the direction of "pioneering science - lifelong care", considering this a guiding principle for its research, production, and distribution activities. Following this direction, the company continuously enhances product quality, standardizes operational systems, and expands access to safe, effective healthcare solutions for customers.
A company representative stated that its three consecutive years in the "Top 10 Reputable Pharmaceutical Distribution Companies" reflects how the market and society perceive the company amidst the pharmaceutical industry's increasingly higher standards. This recognition serves as a foundation for Thai Minh to further strengthen its scientific base, refine its distribution system, and expand collaborations, aiming to bring safe, effective healthcare solutions closer to the public.
 |
Product line and quality control ensure safe and effective products before market release. Photo: Thai Minh |
In addition to the "Top 10 Reputable Pharmaceutical Distribution Companies 2025" ranking, Vietnam Report also ranks other categories in the medical and pharmaceutical sector: "Top 10 Reputable Pharmaceutical Manufacturing Companies 2025", "Top 5 Reputable Traditional Medicine Companies 2025", "Top 10 Reputable Medical Equipment and Healthcare Companies 2025", and "Top 10 Reputable Private Hospitals 2025".
Kim Anh
